European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM<i> Candida</i> III study

MC Arendrup, S Arikan-Akdagli, KM Jorgensen, A Barac, J Steinmann, C Toscano, VA Arsenijevic, A Sartor, C Lass-Flörl, A Hamprecht, T Matos, BRS Rogers, I Quiles, J Buil, V Özenci, R Krause, M Bassetti, L Loughlin, B Denis, A GranciniPL White, K Lagrou, B Willinger, R Rautemaa-Richardson, P Hamal, B Ener, T Unalan-Altintop, E Evren, S Hilmioglu-Polat, Y Oz, OK Ozyurt, F Aydin, F Ruzicka, EFJ Meijer, JP Gangneux, DEA Lockhart, N Khanna, C Logan, U Scharmann, G Desoubeaux, E Roilides, AF Talento, K van Dijk, P Koehler, J Salmanton-García, OA Cornely, M Hoenigl

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)428-437
Number of pages10
JournalJournal Of Infection
Volume87
Issue number5
DOIs
Publication statusE-pub ahead of print - 8 Nov 2023

Keywords

  • C. parapsilosis
  • Candida
  • EUCAST
  • Echinocandin resistance
  • Fks1
  • Fluconazole resistance

Cite this